Skip to main content
. 2020 Jun 19;11(6):475. doi: 10.1038/s41419-020-2550-9

Fig. 3. RP11-142A22.4 upregulation predicts aggressive clinical-pathological characteristics and regulates preadipocyte differentiation in vitro.

Fig. 3

a RP11-142A22.4 expression in adipose tissues from 60 obese patients and 40 lean patients. b Pearson correlation between RP11-142A22.4 expression and BMI in the adipose tissues of 60 obese patients. c ROC curve for RP11-142A22.4 that indicates a diagnostic value for this lncRNA in obese patients. d Valuation of RP11-142A22.4 expression after siRNA treatment using qRT-PCR. e, f C/EBP-α and PPAR-γ expression was quantified using qRT-PCR after RP11-142A22.4 knockdown during preadipocytes differentiation. g Oil red O staining of differentiated preadipocytes after transfection with RP11-142A22.4 specific siRNA versus scramble controls. Scale bar = 100 µm. h C/EBP-α and PPAR-γ expression was quantified using western blot assay after RP11-142A22.4 knockdown during preadipocytes differentiation. Data are presented as means ± SD; significant difference was identified with Student’s t test. *P < 0.05; **P < 0.01; ns, not significant.